Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna-Maria Hoffmann-Vold

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Rheumatology|December 3, 2015
Dr. Hoffmann-Vold repliesAnna-Maria Hoffmann-Vold
Current Opinion in Rheumatology|July 9, 2016
Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosisØyvind Molberg, Anna-Maria Hoffmann-Vold
The Lancet. Rheumatology|August 15, 2025
Further progression in patients with systemic sclerosis-associated interstitial lung disease - Authors' replyAnna-Maria Hoffmann-Vold, Oliver Distler,
Zeitschrift Fur Rheumatologie|September 6, 2019
[New ways in the treatment of SSc-ILD: what makes sense?]Michael Kreuter, Anna-Maria Hoffmann-Vold
Current Opinion in Rheumatology|September 5, 2020
Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosisAnna-Maria Hoffmann-Vold, Øyvind Molberg
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2018
CCL21 as a potential biomarker for pulmonary arterial hypertension in systemic sclerosisAnna-Maria Hoffmann-Vold, Øyvind Molberg
Thorax|August 27, 2021
One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?Anna-Maria Hoffmann-Vold, Michael Kreuter
Journal of Scleroderma and Related Disorders|April 6, 2022
Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approachesAnna-Maria Hoffmann-Vold, Elizabeth R Volkmann
European Journal of Rheumatology|January 11, 2020
Gastrointestinal tract microbiota modifications in systemic sclerosisElizabeth R Volkmann, Anna-Maria Hoffmann-Vold
Arthritis & Rheumatology (Hoboken, N.J.)|May 14, 2019
ReplyMuriel Elhai, Anna Maria Hoffmann-Vold, Yannick Allanore
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Rheumatology|December 3, 2015
Dr. Hoffmann-Vold repliesAnna-Maria Hoffmann-Vold
Current Opinion in Rheumatology|July 9, 2016
Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosisØyvind Molberg, Anna-Maria Hoffmann-Vold
The Lancet. Rheumatology|August 15, 2025
Further progression in patients with systemic sclerosis-associated interstitial lung disease - Authors' replyAnna-Maria Hoffmann-Vold, Oliver Distler,
Zeitschrift Fur Rheumatologie|September 6, 2019
[New ways in the treatment of SSc-ILD: what makes sense?]Michael Kreuter, Anna-Maria Hoffmann-Vold
Current Opinion in Rheumatology|September 5, 2020
Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosisAnna-Maria Hoffmann-Vold, Øyvind Molberg
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2018
CCL21 as a potential biomarker for pulmonary arterial hypertension in systemic sclerosisAnna-Maria Hoffmann-Vold, Øyvind Molberg
Thorax|August 27, 2021
One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?Anna-Maria Hoffmann-Vold, Michael Kreuter
Journal of Scleroderma and Related Disorders|April 6, 2022
Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approachesAnna-Maria Hoffmann-Vold, Elizabeth R Volkmann
European Journal of Rheumatology|January 11, 2020
Gastrointestinal tract microbiota modifications in systemic sclerosisElizabeth R Volkmann, Anna-Maria Hoffmann-Vold
Arthritis & Rheumatology (Hoboken, N.J.)|May 14, 2019
ReplyMuriel Elhai, Anna Maria Hoffmann-Vold, Yannick Allanore
Pageof 17